Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sepracor-Looks very promising -- Ignore unavailable to you. Want to Upgrade?

To: M. Ramle who wrote (886)	6/10/1998 11:05:00 PM
From: John R. Sashko	Read Replies (1) \| Respond to of 10280

Mazen, Take a look at ALK's chart. Very similar to SEPR. Both bounced off the 200 day MA after being beaten down for no reason. I bot ALK calls before it broke the 50 day MA. Risky but I would have missed much of the upside move. For SEPR to hit 43 would mean crossing the 50 day MA. This would be another buy signal which will lead to more institutional buying. The MACD histogram bottomed several days ago and continues to tick up. A low risk, high reward opportunity like this needs to be pounced on. Remember, the drugs under redevelopment had 12 BILLION in sales in 1997. Need to be in this before Levalbuterol is released. I believe SEPR will be in the 80-100 range by years end. Happy Trading, John